Rajkumari, Meenakshi Sharma, Sagarika Majhi, Madhu Verma, Iti Chauhan, Abhilasha Mittal
Rajkumari1*, Meenakshi Sharma1, Sagarika Majhi1, Madhu Verma1, Iti Chauhan1, Abhilasha Mittal2
1Department of Pharmacognosy, I.T.S College of Pharmacy, Muradnagar, Ghaziabad, Uttar Pradesh India.
2Department of Chemistry, NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, India.
Volume - 15,
Issue - 1,
Year - 2023
Medicinal herbs have been passed down through the generations as a gift to humanity. Asia has a wide range of medicinal plants. The Gandoderma lucidum (langzhi) is a well-known plant among Asian populations and often utilised medicinal herbs. The main objective of this review is to document the therapeutic value of G. lucidum. Data was gathered by evaluating more than 70 articles from various web portals. The information gathered was analysed and provided in both descriptive and tabular formats. The outcome reveals that G. lucidum (Langzhi), a member of the Polyporaceae/Ganodermataceae family, is a well-known and widely utilised plant in Asia, used by practically all ethnic groups. Traditional and allopathic medicine both employ this herb. The "Spore Separation Cultivation Method," developed in 1975 in China, is utilised to successfully produce Ganodermas; it is popular due to the country's favourable climate and soil conditions. G.lucidum has been utilised as a panacea for chronic diseases such as hepatopathy, nephritis, hypertension, arthritis, sleeplessness, bronchitis, asthma, diabetes, and cancer in eastern traditional medicine. Owing to its magical medicinal properties it was regarded as an elixir that could revive the dead. This review summarized important areas of investigation being performed on Gandoderma speciesaround the world, with particular emphasis on chemicals of biomedical relevance.
Cite this article:
Rajkumari, Meenakshi Sharma, Sagarika Majhi, Madhu Verma, Iti Chauhan, Abhilasha Mittal. A Review on the significance of the Medicinal plant Gandoderma lucidum. Research Journal of Pharmacognosy and Phytochemistry. 2023; 15(1):46-52. doi: 10.52711/0975-4385.2023.00008
Rajkumari, Meenakshi Sharma, Sagarika Majhi, Madhu Verma, Iti Chauhan, Abhilasha Mittal. A Review on the significance of the Medicinal plant Gandoderma lucidum. Research Journal of Pharmacognosy and Phytochemistry. 2023; 15(1):46-52. doi: 10.52711/0975-4385.2023.00008 Available on: https://rjpponline.org/AbstractView.aspx?PID=2023-15-1-8
1. Datta I C. Non-timber forest product of Nepal. Identification, Classification, Ethanic Use and Cultivation. 2007.
2. Gahatraj S, Bhusal B, Sapkota K, Dhami, B, Gautam D. Common medicinal plants of Nepal: A review of Triphala: Harro (Terminalia chebula, Barro (Terminalia bellirica) and Amala (Emblica officinalis). Journal of Pharmacognosy 2020; 4 (3): 5-13.
3. Jonathan SG, Kigigha LT, Ohimain E. Evaluation of the inhibitory potentials of eight higher Nigerian fungi against pathogenic microorganisms. African Journal of Biomedical Research 2008; 11: 197-202.
4. Sabulal B, Anil JJ, Balaji G. Secondary Metabolites from Ganoderma. Phytochemistry 2015; 114: 66-101.
5. Malarvizhi K, Pudupalayam TK. Ganoderma austral from southern India. Microbiological Research 2008; 163: 286-292.
6. Smith JE, Rowan NJ, Sullivan R. Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities. Biotechnology Letters 2002; 24: 1839-1845.
7. Russell R, Paterson M. Ganoderma- A therapeutics fungal biofactory. Phytochemistry 2006; 67: 1985-2001.
8. Ziegenbein FC, Hanssen HP, Konig WA. Secondary metabolites from Ganoderma lucidum and Spongiporus leucomallellus. Phytochemistry 2006; 67: 202-211.
9. Johnsston N. Medicinal mushroom cuts off prostate cancer cells blood supply. Drug Discovery Today 2005; 10: 23-24.
10. Ursula K, David RN, Chang LGY, Jianhui Z, Jianqin L. Genome analysis of medicinal Ganoderma spp. with plant-pathogenic and saprotrophic life-styles. Phytochemistry 2015; 114: 18-37.
11. Chen S, Xu JLC, Zhu Y, Nelson DR, Zhou SLC, Wang L, Guo X S, Luo HLY, Song J, Henrissar B, Levasseur A, Qian J, Li J, Li J, Luo X, Shi L. Genome sequence of the model medicinal mushroom Ganoderma lucidum. Nature Communication 2012; 3: 913-920.
12. Flood J, Bridge PD, Holderness M. Ganoderma disease of Perennial crops, CABI Publishing, Wallingford, UK December 2000.
13. Zhou XW, Cong WR, Su KQ, Zhang YM. Ligninolytic enzymes from Ganoderma spp.: Current status and potential applications. Critical Review of Microbiology 2013; 39: 416-426.
14. Soniamol J, Baby S, Varughese G, Thozhuthumparambal PS, Kainoor KJ. Antioxidative and Antiinflammatory activities of the chloroform extract of Ganoderma lucidum found in South India. Science Pharmaceuticals 2009; 77(1): 111-122.
15. Ko HH, Hung CF, Wang JP, Lin CN. Anti-inflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry 2008; 69: 2ds34-239.
16. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology 2002; 60: 258-274.
17. Timilsina S, Bhattarai R, Miya M, Gautam D. Sissoo its Pathogenic Constraints and their management in Nepal: A review. Grassroot Journal of Natural Resources 2020; 3 (4): 1-17.
18. Loyd AL, Richter BS, Jusino MA, Truong C, Smith JA. Identifying the Mushroom of Immortality: Assessing the Ganoderma species composition in Commercial Reishi Product. Frontiers in Microbiology 2018; 9: 1557.
19. Loyd AL, Barnes CW, Held BW, Smith JA, Blanchette RA. Ellucidating lucidum: Distribution the diverse laccate Ganoderma species of the United States. PLOS ONE 2018;13 (7) : e 0199738.
20. Chen XH, Yang Z, Huang, XX, Gao M, Tang TW., Chan, SY.2006. Monitoring of immune responses to a herbal immune-modulator in patients with advanced colorectal cancer. International Immunopharmacology 2006; 6: 499-508.
21. Rosecke J, Konig WA. Constituents of various wood-rotting basidiomycetes. Phytochemistry 2000; 54: 603-610.
22. Huie CW, Di X. 2004. Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components. Journal of Chromatography B 2004; 812: 241-257.
23. Chen DH, Shiou WY, Wang KC, Huang SY, Shie YT, Tsai CM, Shie JF, Chen KD. Chemotaxonomy of triterpenoids pattern of HPLC of Gandoderma lucidum and Gandoderma tsugae. Journal of Chinses Chemical Society 1999; 46: 47-51.
24. Cole RJ, Schweikert MA. Handbook of Fungal Secondary Metabolites, volume 2, Academic Press, California 2003.
25. Cole RJ, Schweikert MA. Handbook of Fungal Secondary Metabolites, volume 3, Academic Press, California 2003.
26. Akihisa T, Tagata M, Ukiya M, Tokuda H, Suzuki T, Kimura Y. 2005. Oxygenated lanostane type triterpenoids from the fungus Ganoderma lucidum. Journal of Natural Products 2005; 68: 559-563.
27. Adams M, Christen M, Plitzko I, Zimmermann S, Brun R, Kaiser M, Hamburger M. 2010, Antiplasmodial lanostanes from the Ganoderma lucidum mushroom. Journal of Natural Products 2010; 73: 897-900.
28. Lee I, Kim H, Youn U, Kim J, Min B, Jung H, Na M, Hattori M, Bae K. Effect of lanostane triterpenes from the fruiting bodies of Ganoderma lucidum on adipocyte differentiation in 2T3-LI cells. Planta Medica 2010a; 76: 1558-1563.
29. Li C, Yin J, Guo F, Zhang D, Sun HH. Ganoderic acid Sz, a new lanostanoids from the mushroom Ganoderma lucidum. Natural Product Research 2005b; 19: 461-465.
30. Li C, Li Y, Sun HH. New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum. Natural Product Research 2006; 20: 985-999.
31. Li YB, Liu RM, Zhong JJ. A new ganoderic acid from Ganoderma lucidum mycelia and its stability. Fitoterapia 2013c; 84: 115-122.
32. Xiaomei S, Wang H, Xiaofenga H, Shangwei C, Song Z, Jun D. Fingerprint analysis of polysaccharides from different Ganoderma by HPLC combined with chemometrics methods. Carbohydrate Polymers 2014;114: 432-439.
33. Liu W, Wang HY, Pang XB, Yao WB, Goa XD. Characterization and antioxidant activity of two low molecular weight polysaccharides purified from the fruiting bodies of Ganoderma lucidum. International Journal of Biological Macromolecules 2010; 46: 451-457.
34. Xu ZT, Chen XU, Zhong ZF, Chen LD, Wang YT. Ganoderma lucidum polysaccharides: Immunomodulation and potential anti-tumor activities. The American Journal Journal of Chinese Medicine 2011; 39 (1): 15-27.
35. Zhang H, Li WJ, Nie SP, Chen Y, Wang YX, Xie MY. Structural characterization of a noval bioactive polysaccharide from Ganoderma atrum. Carbohydrate Polymers 2012; 88 (3):1047-1054.
36. Yong MY, Xin LW, Qi L, Li PJ, Cui PY, Bo H. Zhi LZ, Yong BC, Yong XC. Metabolites from the mushroom Ganoderma lingzhi as stimulators of neural stem cell proliferation. Phytochemistry 2015;114: 155-162.
37. Eva C, Jose LM, Pilar S, Cristina MT, Angel H, Jose CD. Ganoderma lucidum induced apoptosis in NB4 human leukemia cells: Involvement of Akt and Erk. Jounal of Ethanopharmacology 2010; 128: 71-78.
38. Shih CH, Chien CO, Jhy WL, Tzu CC, Han PK, Jah YL, Chin SC, Song CL, Ching HS, Ming CK. Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G2/M cell cycle arrest. Journal of Ethanopharmacology 2008;120: 394-401.
39. Chien RC, Yen MT, Seng YH, Mau, JL. Chemical characteristics and anti-proliferation activities of Ganoderma tsugae Polysaccharides. Carbohydrate polymers 2015;128 (5): 90-98.
40. Ulrike L, Wolf DJ, Sabine W. Ganoderma pfeifferi- A European relative of Ganoderma lucidum. Phytochemistry 2015;114: 102-108.
41. Alex EA, Elaine RC, Rita CGS, Marina KK, Guilherme LS, Clarice AO, Philip AJG, Marcello L. An unusual water soluble β-glucan from the basidiocarp of the fungus Ganoderma resinaceum. Carbohydrate Polymers 2008; 78: 473-478.
42. Pei G, Tomoya H, Zhiqing C, Tadashi Y, Yoshihiro N, Akiko S. Isolation and Identification of C-19 fatty acids with anti-tumor activity from the spores of Ganoderma lucidum (reishi mushroom). Fitoterapia 2012; 83(3): 490-499.
43. Li LH, Qing YM, Sheng ZH, Zhi XM, Jian CG, Hao FD, You XZ. A new nortriterpenoid from the fruiting bodies of Ganoderma tropicum. Phytochemistry Letters 2014; 7: 11-13.
44. Sri F, Ryuichiro K, Kuniyoshi S. Structure-activity relationships of lanostane type triterpenoids from Ganoderma lingzhi as α-glucosidase inhibitors. Bioorganic and Medicinal Chemistry Letters 2013; 23: 5900-5903.
45. Min Y, Xiaoming W, Shuhong G, Jiameng X, Jianghao S, Hui G, De G. Analysis of Triterpenoids in Ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry. Journal of the American Society for Mass Spectrometry 2017; 18: 927-939.
46. Lin CN, Tome WP, Won SJ. Novel cytotoxic principles of Formosan Ganoderma lucidum. Journal of Natural Product 1993; 54: 998-1002.
47. Kim BK, Cho HY, Kim JS, Kim HW, Choi EC. Studies on constituents of higher fungi of Korea Antitumor components of the cultured mycelia of Ganoderma lucidum. Korean Journal of Pharmacology1993; 24: 203-212.
48. Kuo MC, Weng CY, Ha CL, Wu, MJ. Ganoderma lucidum mycelia enhanced innata immunity by activating NF-Κb. Journal of Ethanopharmacology 2006; 103: 217-222.
49. Hajjaj H, Mace C, Roberts M, Niederberger P, Fay LB. Effect of 26-Oxygenosterole from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors. Applied Environmental Microbiology 2005; 71: 3653-3658.
50. Min BS, Nakamura N, Miyashiro H, Bae KW, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chemical Pharmaceutical Bulletin (Tokyo) 1998; 46: 1607-1612.
51. Kim KC, Kim IG. Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation. International Journal of Molecular Medicine1999b; 4: 273-277.
52. Tanaka S, Ko K, Kino K, Tsuchiya K, Yamashita A, Murasugi A, Sakuma S, Tsunoo H. Complete amino acid sequence of an immunomodulatory protein, ling zhi-8 (LZ-8). An immunomodulator from a fungus, Ganoderma lucidum, having similarity to immunoglobulin variable regions. Journal of Biological Chemistry 1989; 264: 16372-16377.
53. Ngai PHK, Ng TB. A mushroom (Ganoderma capense) lectin with spectacular thermostability, potent mitogenic activity on splenocytes and antiproliferative activity towards tumor cells. Biochemistry and Biophysics Research Communication 2004; 314: 988-993.
54. Gau JP, Lin CK, Lee, SS, Wang SR. The lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs. American Journal of Chinese’s Medicines 1990; 18: 175-179.
55. Zhe J, Qingjiu T, Jinsong Z, Yan Y, Wei J, Yingjie P. Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. Journal of Ethanopharmacology 2007; 112: 445-450.
56. Jie L, Kuniyoshi S, Fumiko K, Shoichiro K, Ryuichiro K. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Bioorganic and Medicinal Chemistry 2007; 15: 4966-4972.
57. Rumi F, Jie L, Kuniyoshi S, Fumiko K, Kiyoshi N, Shoichiro K, Chie U, Hisatoshi T, Shuhei K, Yoshitaro S, Ryuichiro K. Anti-androgenic activities of Ganoderma lucidum. Journal of Ethanopharmacology 2005; 102: 107-112.
58. Xiaomei S, Haohao W, Xiaofeng H, Shangwei Chen, Song Z, Jun D. Fingerprint analysis of Polysaccharides from different Ganoderma by HPLC combined with chemometrics methods. Carbohydrate Polymers 2014; 114: 432-439.
59. Jie L, Jun S, Kuniyoshi S, Akiko K, Toshio K, Ryuichiro K. Ganoderic acid DM: Anti-androgenic osteoclastogenesis inhibitor. Bioorganic and Medicinal Chemistry Letters 2009; 19: 2154-2157.
60. Ross RK, Bernstein L, Lobo RA. 5α-Reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992; 339: 887-889.
61. Jiang J, Slivova V, Sliva D. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. International Journal of Oncology 2006; 29: 695-703.
62. Shailesh D, Anita T, Daniel S. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. International Immunopharmacology. 2009; 9:1272-1280.
63. Zi YZ, Yu PT, Jun X, Pin W, Hui MJ, Zhong W, Masao M, Ding FC. Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. Journal of Ethanopharmacology 2010; 131: 154-164.
64. Yuen JWM, Gohel MDI, Ng CF. The differential immunological activities of Ganoderma lucidum on human pre-cancerous uroepithelial cells. Journal of Ethanopharmacology 2011; 135:711-718.
65. Horng HK, Chi FH, Jih PW, Chun NL. Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry 2008; 69: 234-239.
66. Xiang YC, Su YC, Juan Z, Zi JW, Bin Y, Zhao FS, Xue QZ, Yong HZ. Extract of Ganoderma lucidum prolongs sleep time in rats. Journal of Ethanopharmacology 2012; 139: 796-800.
67. Isabel CFRF, Sandrina AH, Filipa SR, Dejan S, Maria JRP, Queirz MHV, Marina S. Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities. Phytochemistry 2014; 114: 38-55.
68. Masahiko I, Panida C, Surisa K, Kitlada S, Rattaket C. Lanostane triterpenes from cultures of the Basidiomycete Ganoderma orbiforme BCC 22324. Phytochemistry 2013; 87: 133-139.
69. Xiaobo S, Chen Z, Wei P, Jinping W, Weijun W. Carboxylate groups play a major role in antitumor activity of Ganoderma applanatum polysaccharide. Carbohydrate Polymers 2015; 123: 283-287.
70. Haou TM, Jung FH, Shui TC. Anti-diabetic effects of Ganoderma lucidum. Phytochemistry 2015; 114: 109-113.
71. Jasmina C, Jelena V, Mirjana S, Tatjana S, Jasmina G. Biological activity of Ganoderma lucidum basidiocarps cultivated on alternative and commercial substrate. Journal of Ethanopharmacology 2014; 155: 312-319.